6-aminonicotinamide has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Chen, H; Chen, Y; Huang, R; Ji, D; Li, T; Wan, B; Wei, Y; Xu, Q; Yuan, L | 1 |
1 other study(ies) available for 6-aminonicotinamide and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Inhibition of pentose phosphate pathway suppresses acute myelogenous leukemia.
Topics: 6-Aminonicotinamide; Cell Line, Tumor; Cell Movement; Cell Proliferation; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Genetic Variation; Glucose; Humans; Leukemia, Myeloid, Acute; Oxidation-Reduction; Pentose Phosphate Pathway; Prognosis | 2016 |